Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 04, 2015 5:26 PM ET


Company Overview of Five Prime Therapeutics, Inc.

Key Executives for Five Prime Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Lewis T. Williams M.D., Ph.D.40 RelationshipsFounder, Chief Executive Officer, President and Director66
Marc L. Belsky No RelationshipsChief Financial Officer and Senior Vice President60
Julie Hambleton M.D. No RelationshipsChief Medical Officer and Executive Vice President57
Aron Marc Knickerbocker 14 RelationshipsChief Business Officer, Executive Vice President and Director46
Francis W. Sarena No RelationshipsExecutive Vice President, General Counsel and Secretary44

Five Prime Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Brian G. Atwood MBA 200 RelationshipsVersant Ventures, Inc.62
Lewis T. Williams M.D., Ph.D. 40 RelationshipsFive Prime Therapeutics, Inc.66
Aron Marc Knickerbocker 14 RelationshipsFive Prime Therapeutics, Inc.46
Mark D. McDade 54 RelationshipsUCB S.A.60
Franklin M. Berger CFA, BA, MA, MBA 104 RelationshipsFive Prime Therapeutics, Inc.65
View All Board Members

Five Prime Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CFA, BA, MA, MBAFranklin M. Berger104 Relationships3 Executives
Compensation Committee Mark D. McDade54 Relationships3 Executives
Nominating Committee M.D.Peder K. Jensen34 Relationships4 Executives
Corporate Governance Committee M.D.Peder K. Jensen34 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$525.0K
Total Value of Options
Compensation as of Fiscal Year
Five Prime Therapeutics, Inc. CEO Compensation
Industry Average


SC Johnson Appoints Ann Mukherjee as Global Chief Marketing Officer
October 02, 2015 12:00 AM ET
Spectrum Brands Holdings, Inc. Announces Changes to the Board of Directors
September 28, 2015 12:00 PM ET
Mary Agnes Wilderotter Does Not Stand for Re-Election to Board of Directors of The Procter & Gamble Company
September 25, 2015 8:00 PM ET
The National Detergent Company S.A.O.G. Announces Board Changes
September 21, 2015 7:50 AM ET
Procter & Gamble Announces Retirement of Tarek Farahat as President of Latin America Selling and Market Operations
September 18, 2015 4:32 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Five Prime Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at